RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | 0.0% | 1,686 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 1,686 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 1,686 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -42.9% | 1,686 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $14,000 | -54.8% | 1,686 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $31,000 | +138.5% | 1,686 | +41.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | +8.3% | 1,196 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | +71.4% | 1,196 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -12.5% | 1,196 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -11.1% | 1,196 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +50.0% | 1,196 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | -53.8% | 1,196 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $13,000 | +18.2% | 1,196 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $11,000 | +22.2% | 1,196 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | +12.5% | 1,196 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | – | 1,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |